Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medical Ikkou Group CoTSE:3353 -0.25%68 Earnings Yield (Joel Greenblatt) % is 12.99% as of Feb. 2026, which is 27% above its 10-year median of 10.25. GuruFocus rates TSE:3353 with a GF Score™ of 68/100 and a GF Value™ of 円3,625.73 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 562 Conglomerates companies, Medical Ikkou Group Co ranks better than 78.83% on this metric.
Medical Ikkou Group Co's Enterprise Value for the quarter that ended in Feb. 2026 was 円16,383 Mil.
Medical Ikkou Group Co's EBIT for the trailing twelve months (TTM) ended in Feb. 2026 was 円2,127 Mil. Medical Ikkou Group Co's Earnings Yield (Joel Greenblatt) for the quarter that ended in Feb. 2026 was 12.99%.
The historical rank and industry rank for Medical Ikkou Group Co's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
TSE:3353'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: 4.62 Med: 10.25 Max: 17.61
Current: 13.79
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of Medical Ikkou Group Co was 17.61%. The lowest was 4.62%. And the median was 10.25%.
TSE:3353's Earnings Yield (Joel Greenblatt) % is ranked better than 78.83% of 562
companies
in the Conglomerates industry
Industry Median: 6.615
vs TSE:3353: 13.79
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Medical Ikkou Group Co's Forward Rate of Return (Yacktman) % for the quarter that ended in Feb. 2026 was 16.47%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Medical Ikkou Group Co (TSE:3353) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Medical Ikkou Group Co Earnings Yield (Joel Greenblatt) % Related Terms
Medical Ikkou Group Co Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Medical Ikkou Group Co's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medical Ikkou Group Co Earnings Yield (Joel Greenblatt) % Chart
TSE:3353 vs MMM, HON: Earnings Yield (Joel Greenblatt) % Comparison
For the Conglomerates subindustry, Medical Ikkou Group Co's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medical Ikkou Group Co Earnings Yield (Joel Greenblatt) % vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Medical Ikkou Group Co's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Medical Ikkou Group Co's Earnings Yield (Joel Greenblatt) % falls into.
Medical Ikkou Group Co Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Medical Ikkou Group Cos Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Feb. 2026 is calculated as
For company reported semi-annually or annually, GuruFocus only calculate annual data for Earnings Yield (Joel Greenblatt) and apply the annual figure to corresponding quarter.
What does a Earnings Yield (Joel Greenblatt) % of 12.99% mean?
Medical Ikkou Group Co (TSE:3353) has a Earnings Yield (Joel Greenblatt) % of 12.99% as of Feb. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Medical Ikkou Group Co and its competitors. This is 27% above median its historical median of 10.25. Over the past decade, Medical Ikkou Group Co's Earnings Yield (Joel Greenblatt) % has ranged from 4.62 to 17.61. According to the industry distribution chart, Medical Ikkou Group Co ranks #119 out of 562 companies in the Conglomerates industry, placing it in the top 21.2%.
Is Medical Ikkou Group Co's Earnings Yield (Joel Greenblatt) % too high?
Medical Ikkou Group Co's current Earnings Yield (Joel Greenblatt) % of 12.99% is 27% above median its 10-year median of 10.25. Over the past 10 years, this metric has ranged from a low of 4.62 to a high of 17.61. The Conglomerates industry median Earnings Yield (Joel Greenblatt) % is 6.62. Medical Ikkou Group Co's value of 12.99% is 96.4% above this industry median. Based on the distribution chart, Medical Ikkou Group Co ranks #119 out of 562 companies in the Conglomerates industry, which is in the top quartile — a strong position relative to peers. Overall, Medical Ikkou Group Co has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medical Ikkou Group Co's Earnings Yield (Joel Greenblatt) % compare to MMM and HON?
According to the Conglomerates industry distribution chart, Medical Ikkou Group Co ranks #119 out of 562 companies for Earnings Yield (Joel Greenblatt) %. This places Medical Ikkou Group Co in the top 21% of its industry — outperforming the majority of peers. The industry median Earnings Yield (Joel Greenblatt) % is 6.62. Medical Ikkou Group Co's value of 12.99% is 96.4% above this benchmark. Historically, Medical Ikkou Group Co's own Earnings Yield (Joel Greenblatt) % has ranged from 4.62 to 17.61 over the past decade. While the company's 10-year median is 10.25 vs. the industry median of 6.62, Medical Ikkou Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Conglomerates company?
The median Earnings Yield (Joel Greenblatt) % among Conglomerates companies is 6.62, based on 562 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medical Ikkou Group Co's current Earnings Yield (Joel Greenblatt) % of 12.99% is 96.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Medical Ikkou Group Co and its competitors. For the Conglomerates industry, the median Earnings Yield (Joel Greenblatt) % is 6.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Ikkou Group Co's current Earnings Yield (Joel Greenblatt) % is 12.99%, which is 27% above median its own 10-year median of 10.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Ikkou Group Co stock overvalued right now?
Based on GuruFocus' analysis, Medical Ikkou Group Co (TSE:3353) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,625.73, compared to a current price of 円2,797.00 — trading 22.9% below its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 12.99%, which is 27% above median its 10-year median of 10.25 and 96.4% above the Conglomerates industry median of 6.62. Medical Ikkou Group Co's overall GF Score™ is 68/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Medical Ikkou Group Co (TSE:3353), the current Earnings Yield (Joel Greenblatt) % is 12.99% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medical Ikkou Group Co (TSE:3353) Overvalued in 2026?
Based on GuruFocus' analysis, Medical Ikkou Group Co stock appears to be undervalued.
The current stock price of 円2,797.00 is trading 22.9% below its estimated GF Value™ of 円3,625.73.
GuruFocus considers Medical Ikkou Group Co to be Modestly Undervalued.
Key valuation signals for TSE:3353:
Earnings Yield (Joel Greenblatt) %: 12.99% (27% above median its 10-year median of 10.25)
GF Value™: 円3,625.73 vs. price of 円2,797.00 (22.9% below fair value)
Industry Position: 96.4% above the Conglomerates median (#119 of 562)
No single metric tells the full story. See the TSE:3353 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medical Ikkou Group Co Ltd is engaged in Dispensing pharmacy business, healthcare business, pharmaceutical wholesale business, real estate business, and investment business.
68GF Score
Get the complete analysis for TSE:3353
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3353 has been successfully added to your 
